Healthcare Industry News: Clinical Event Interface
News Release - February 14, 2006
Spacelabs Medical Launches Clinical Event Interface for Secondary Alarm NotificationBOCA RATON, Fla. & ISSAQUAH, Wash.--(HSMN NewsFeed)--Feb. 14, 2006--Spacelabs Medical, a global leader in patient monitoring systems, announced the launch of its new Clinical Event Interface (CEI) for secondary patient alarm notification. In keeping with Spacelabs' commitment to open standards and connectivity, the CEI is designed to connect with Emergin's Patient Monitoring Gateway, enabling nurses to receive alarms directly, even if they are away from the bedside or central stations. The new messaging interface solution, part of Spacelabs' Intesys® Clinical Suite (ICS), will be available initially in the US and Canada.
The Spacelabs messaging solution relays patient alarm messages from Spacelabs patient monitors, including those from devices connected via Flexport technology, directly to the Emergin Gateway where messages are routed to caregiver pagers, wireless phones, badges or LED signs. The new secondary messaging system will be showcased at the Healthcare Information and Management Systems Society (HIMSS) annual conference, February 12-16 in San Diego.
Designed to give hospitals a high degree of functionality and the broadest possible options in communications systems, the CEI integrates seamlessly with the Emergin Patient Monitoring Gateway, improving staff efficiency and enhancing patient care. The new ICS product is fully compatible with Spacelabs UltraviewSL(TM), Ultraview® and PCMS® monitors. It is especially well-suited for telemetry departments and care areas with private rooms because it can send text messages, waveforms or both to caregivers whenever and wherever they need the information.
"By partnering with Emergin, Spacelabs Medical can now offer customers more choices and connect patient monitors via the Clinical Event Interface with virtually any commercial device - offering a broader opportunity for expanded communications," said Michael A. McNeal, President & CEO of Emergin.
"The CEI solution enables Spacelabs to further support our customers' needs for connectivity, access to time-critical information when and where it's needed and maximum flexibility in their choice of systems," said Jonathan Lauer, Vice President of Global Strategic Marketing for Spacelabs. "All this adds up to what clinicians value most - more time for patient care."
About Emergin, Inc.
Emergin is the plug-and-play integration company. Through its decade of innovation, Emergin has integrated over 200 disparate technologies to enable better collaboration and provide improved communications for healthcare enterprises. Emergin has provided packaged solutions for over 1,000 healthcare organizations, including 3 of the last 3 Malcolm Baldrige Quality Award recipients, 30 of the 180 Magnet Hospitals and 6 of the Top-10 Heart Hospitals.
About Spacelabs Medical
Spacelabs Medical (www.spacelabs.com), based in Issaquah, WA, U.S., is a global manufacturer and distributor of patient monitoring systems for critical care and anesthesia, wired and wireless networks and clinical information connectivity solutions, ambulatory blood pressure (ABP) monitors and medical data services. It has sold approximately 117,000 patient monitoring units worldwide. Spacelabs Medical has distribution partnerships in approximately 80 countries and sales or regional offices throughout the world. The company has approximately 800 employees. Spacelabs Medical is a division of Spacelabs Healthcare Inc. (www.spacelabshealthcare.com).
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare (www.spacelabshealthcare.com), Inc. is an international developer, manufacturer and distributor of medical equipment and services including patient monitoring solutions, anesthesia delivery and ventilation systems, pulse oximeters and sensors and bone densitometers selling to hospitals, clinics and physicians offices. Additionally, the company provides ECG laboratory services to pharmaceutical companies undertaking clinical trials, whereby patient ECG data are recorded, analyzed, tabulated and interpreted.
The company has established brand names in both medical devices and medical services such as "Spacelabs," "Blease" and "Dolphin." The company employs approximately 1,050 personnel in its 14 offices in United Stages, UK, Canada, France, Germany, Finland and Singapore. The company conducts its manufacturing and R&D in United States, UK and India.
Spacelabs Healthcare is a subsidiary of OSI Systems, Inc., a US-based, NASDAQ-listed company.
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding our expectations, goals or intentions about the future, including, but not limited to, statements regarding success of the CEI or Emergin's Patient Monitoring Gateway. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in our Securities and Exchange Commission filings. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.